Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us ![]()
About
CPhI WW FrankfurtCPhI WW Frankfurt
Not Confirmed
Not Confirmed
28-30 October, 2025
Not Confirmed
Not Confirmed
26-29 October, 2025
ISPE Annual MeetingISPE Annual Meeting
Not Confirmed
Not Confirmed
26-29 October, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS






Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI WW FrankfurtCPhI WW Frankfurt
Industry Trade Show
Not Confirmed
28-30 October, 2025
Industry Trade Show
Not Confirmed
26-29 October, 2025
ISPE Annual MeetingISPE Annual Meeting
Industry Trade Show
Not Confirmed
26-29 October, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/we-re-expanding-our-cdmo-capabilities-to-meet-the-next-wave-of-complex-therapies-starting-with-oncology
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/cdmo-activity-tracker-veranova-chemexpress-invest-in-adc-facilities-cohance-to-set-up-oligonucleotide-facility-in-india

23 Sep 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/kelun-biotech-to-present-results-from-multiple-clinical-studies-at-the-2025-esmo-congress-302564236.html

22 Sep 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/kelun-biotechs-new-drug-application-for-its-novel-next-generation-selective-ret-inhibitor-a400ep0031-accepted-for-review-by-the-nmpa-for-the-treatment-of-ret-fusion-positive-nsclc-302563729.html

19 Aug 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/nature-medicine-publishes-results-of-phase-ii-study-of-sacituzumab-tirumotecan-plus-tagitanlimab-as-first-line-therapy-for-nsclc-302533389.html

18 Aug 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/kelun-biotech-announces-2025-interim-results-302532141.html

23 Jul 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/kelun-biotechs-partner-windward-bio-announces-initiation-of-a-global-phase-2-asthma-trial-of-skb378win378-302511998.html

11 Jun 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/kelun-biotechs-novel-cldn18-2-adc-skb315-ind-in-combination-with-tagolizumab-receives-nmpa-approval-for-the-first-line-treatment-of-gastricgastro-oesophageal-junction-cancer-302479822.html
ABOUT THIS PAGE